DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Stock Has Average Target Price of $13.31 According to Brokerages

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has received a consensus recommendation of “Hold” from the fourteen research firms that are presently covering the firm, Marketbeat reports. Three research analysts have rated the stock with a sell recommendation, eight have assigned a hold recommendation and three have given a buy recommendation to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $13.31.

XRAY has been the subject of a number of recent analyst reports. BMO Capital Markets cut their target price on DENTSPLY SIRONA from $13.00 to $10.00 and set a “market perform” rating for the company in a research report on Thursday, September 17th. Barrington Research set a $15.00 price target on DENTSPLY SIRONA in a research report on Monday, August 10th. Piper Sandler boosted their price target on DENTSPLY SIRONA from $13.00 to $14.00 and gave the company a “neutral” rating in a research note on Wednesday, July 29th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research report on Monday, August 3rd. Finally, Barclays upped their price objective on shares of DENTSPLY SIRONA from $9.00 to $11.00 and gave the stock an “underweight” rating in a research report on Monday, August 24th.

Institutional Trading of DENTSPLY SIRONA

A number of institutional investors and hedge funds have recently made changes to their positions in the company. BlackRock Inc. bought a new position in DENTSPLY SIRONA in the second quarter valued at approximately $283,405,000. Southpoint Capital Advisors LP acquired a new position in DENTSPLY SIRONA during the first quarter valued at approximately $116,000,000. Edmond DE Rothschild Holding S.A. bought a new stake in DENTSPLY SIRONA during the second quarter worth $47,780,000. Paradigm Capital Management Inc. NY bought a new stake in DENTSPLY SIRONA during the second quarter worth $39,775,000. Finally, Bank of America Corp DE acquired a new stake in shares of DENTSPLY SIRONA in the 2nd quarter valued at $31,001,000. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Down 3.2%

Shares of XRAY opened at $8.98 on Friday. The company has a current ratio of 1.63, a quick ratio of 1.07 and a debt-to-equity ratio of 1.48. DENTSPLY SIRONA has a 12 month low of $8.90 and a 12 month high of $14.76. The firm’s 50 day moving average is $11.35 and its 200-day moving average is $11.30. The stock has a market capitalization of $1.79 billion, a PE ratio of -3.27, a P/E/G ratio of 1.18 and a beta of 0.84.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.17. DENTSPLY SIRONA had a positive return on equity of 20.84% and a negative net margin of 14.99%.The business had revenue of $898.00 million during the quarter, compared to analysts’ expectations of $889.93 million. During the same period in the previous year, the company posted $0.52 earnings per share. The firm’s revenue for the quarter was down 4.1% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Equities research analysts forecast that DENTSPLY SIRONA will post 1.4 EPS for the current year.

About DENTSPLY SIRONA

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental laboratories, and other oral health professionals with solutions spanning preventive, restorative, endodontic, orthodontic, implant, and prosthetic dentistry.

Its portfolio includes dental consumables, equipment and treatment centers, imaging systems, CAD/CAM systems, instruments, dental materials, implants, orthodontic products, and software and digital workflow solutions.